Our study expands this list to include dystonia by revealing that the +142C>T GCH1 5’UTR substitution detected in DRD patients is a functional mutation that reduces translational efficiency and likely leads to reduced wild type GCH1 protein levels, underlying manifestation of DRD. The gene discussed is GCH1; the disease is dystonia 5.